 BOULDER, Colo., May 05, 2022 GLOBE NEWSWIRE -- Brickell Biotech, Inc. Brickell or the Company Nasdaq: BBI, a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases, announced today that it will report its first quarter financial results on Thursday, May 12th. Brickells management will host a conference call and webcast at 4:30 p.m. EDT that same day to discuss the financial results and recent corporate highlights. 